Paper des Monats
30.09.2021 September 2021: iDFS and safety results of the randomized phase III GAIN-2 trial
We are delighted to inform you that our results on the GAIN-2 trial has been published in European Journal of Cancer
30.08.2021 August 2021: Utility of the CPS + EG scoring system in TNBC patients treated with neoadjuvant chemotherapy
We are delighted to inform you that our analysis on the utility of the CPS + EG score in triple-negative breast cancer patients has been published in European Journal of Cancer
19.07.2021 July 2021: Clinical and molecular characteristics of HER2-low-positive breast cancer
We are pleased to inform you that a pooled analysis of patients with HER2-low-positive breast cancer has been published in The Lancet Oncology
30.06.2021 June 2021: Chemotherapy-induced ovarian failure in young women with early breast cancer
A prospective analysis on chemotherapy-induced ovarian failure in young women with early breast cancer has been published in European Journal of Cancer
01.06.2021 May 2021: Therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer
A pooled analysis on therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer has been published in European Journal of Cancer